Healthcare solution provider Twisted Ceptors Corporation has announced their MIMIC network can enable instantaneous, secure transmission of mobile ultrasound imaging and reports, making it easier for providers to share images with patients without requiring the patients to leave their homes.
“We believe this sets us apart from other vendors in this marketplace,” said Michael A. Muscato, Twisted Ceptors founder. “To provide a totally free service that continues to support our mandate of improving patient care through cooperative sharing is a game changer.”
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
By using its MDRIVE “edge” technology, MIMIC has developed what amounts to a mobile radiology office that can immediately send studies and reports to the company’s vendor neutral archive. This functionality requires no USB storage sticks or bulk data transfers, and it prevents incomplete study uploads.
The social network shares image instantly via low-cost communication devices that have financial-grade security and encryption. In addition, 5G-capable network connectivity, as well as the MIMIC cloud, make it possible for mobile imaging technologists to send studies to the physician while still present with the patient.
Social Radiology Network Enables Instant Mobile Ultrasound Imaging Anywhere
Functionality improves patient care by allowing secure image share with providers before technologists leave patients.
Healthcare solution provider Twisted Ceptors Corporation has announced their MIMIC network can enable instantaneous, secure transmission of mobile ultrasound imaging and reports, making it easier for providers to share images with patients without requiring the patients to leave their homes.
“We believe this sets us apart from other vendors in this marketplace,” said Michael A. Muscato, Twisted Ceptors founder. “To provide a totally free service that continues to support our mandate of improving patient care through cooperative sharing is a game changer.”
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
By using its MDRIVE “edge” technology, MIMIC has developed what amounts to a mobile radiology office that can immediately send studies and reports to the company’s vendor neutral archive. This functionality requires no USB storage sticks or bulk data transfers, and it prevents incomplete study uploads.
The social network shares image instantly via low-cost communication devices that have financial-grade security and encryption. In addition, 5G-capable network connectivity, as well as the MIMIC cloud, make it possible for mobile imaging technologists to send studies to the physician while still present with the patient.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
The Reading Room: Information-Blocking and Interoperability Compliance
Matthew Michela, President and CEO of Life Image, discusses ONC information-blocking rules and strategies practices can take to ensure compliance.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
FDA Clears AI Software for Fetal Heart Ultrasound Assessment
Reportedly developed on over 90,000 ultrasound exams, the BrightHeart AI software identifies suspicious findings suggestive of congenital heart defects through AI-powered evaluation of fetal heart morphology.
Ultrasound Device Garners FDA De Novo Nod for Kidney Stone Clearance
Emerging research demonstrated that the Stone Clear device, which facilitates post-lithotripsy clearance of kidney stone fragments, led to a 70 percent lower risk of relapse in comparison to observation in a control group.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
The Reading Room: Information-Blocking and Interoperability Compliance
Matthew Michela, President and CEO of Life Image, discusses ONC information-blocking rules and strategies practices can take to ensure compliance.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
FDA Clears AI Software for Fetal Heart Ultrasound Assessment
Reportedly developed on over 90,000 ultrasound exams, the BrightHeart AI software identifies suspicious findings suggestive of congenital heart defects through AI-powered evaluation of fetal heart morphology.
Ultrasound Device Garners FDA De Novo Nod for Kidney Stone Clearance
Emerging research demonstrated that the Stone Clear device, which facilitates post-lithotripsy clearance of kidney stone fragments, led to a 70 percent lower risk of relapse in comparison to observation in a control group.